Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Xueying Mao(Ministry of Education), Yong‐Jie Lu(Queen Mary University of London), Luis Beltrán(Queen Mary University of London), Bryan D. Young(The University of Texas Southwestern Medical Center), Elzbieta Stankiewicz(Queen Mary University of London), Daniel M. Berney(Queen Mary University of London), R.T.D. Oliver(University of Cambridge), Yongwei Yu(Second Military Medical University), Liyan Xue(Queen Mary University of London), Dongmei Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Guoping Ren(Queen Mary University of London), Lara K. Boyd(Queen Mary University of London), Tracy Chaplin(Queen Mary University of London), Sakunthala C. Kudahetti(Queen Mary University of London), Manu Gupta(Queen Mary University of London)
Cited by 158
Related Papers
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
|Nature Cell Biology|2021|537
Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10
|Cell|2006|460
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
|The Lancet|2005|447
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334